SNDL
Sundial Growers Inc. Common Shares
stock NASDAQ

i actually think it's better that this happened for TRLV (i also don't think this really means much anyway but to the extent it does). Basically TRLV whole business (at least bottom line) is medical. Future growth or at least what I can tell is Georgia and Texas medical. None of that affected by AU S3 delay. TRLV also hasn't really shown it is good at rec but is the best at medical from what we've seen. I actually think it would be bad for TRLV if Florida went rec. Why change what they are dominant at now?

And whether we like to admit it or not, there is definitely limited capital going into cannabis right now. I dont think the dams fully open to big institutions until theres full federal legalization or companies start showing massive growth again. So with that in mind there are only 2 big board listed companies today in the US - TRLV and GLAS. GLAS is absolute trash. So anyone looking for present day US exposure goes to TRLV.
(Side note: SNDL has some US exposure but it's smaller part of their portfolio. CGC i think is losing their US exposure. VFF has a greenhouse in TX but no license. CRON and OGI have big tobacco partners and could build but haven't today yet. So i just left those out and limited to TRLV and GLAS)
If adult use gets rescheduled, CURA, GTI, VRNO, etc all will uplist. And that is more capital competition for TRLV. So while the fundamentals don't get changed, the premium might.
Obviously i bought the dip haha.

i actually think it's better that this happened for TRLV (i also don't think this really means much anyway but to the extent it does). Basically TRLV whole business (at least bottom line) is medical. Future growth or at least what I can tell is Georgia and Texas medical. None of that affected by AU S3 delay. TRLV also hasn't really shown it is good at rec but is the best at medical from what we've seen. I actually think it would be bad for TRLV if Florida went rec. Why change what they are dominant at now?

And whether we like to admit it or not, there is definitely limited capital going into cannabis right now. I dont think the dams fully open to big institutions until theres full federal legalization or companies start showing massive growth again. So with that in mind there are only 2 big board listed companies today in the US - TRLV and GLAS. GLAS is absolute trash. So anyone looking for present day US exposure goes to TRLV.
(Side note: SNDL has some US exposure but it's smaller part of their portfolio. CGC i think is losing their US exposure. VFF has a greenhouse in TX but no license. CRON and OGI have big tobacco partners and could build but haven't today yet. So i just left those out and limited to TRLV and GLAS)
If adult use gets rescheduled, CURA, GTI, VRNO, etc all will uplist. And that is more capital competition for TRLV. So while the fundamentals don't get changed, the premium might.
Obviously i bought the dip haha.